New pill targets leukemia in early trial
NCT ID NCT05918692
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 23 times
Summary
This early-phase study tests a new daily pill called BMF-500 in adults with acute myeloid leukemia (AML) that has come back or not responded to treatment. The drug targets a specific genetic change (FLT3 mutation) found in some leukemias. The main goals are to check safety, find the best dose, and see if the drug can help control the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
City of Hope National Medical Center
Duarte, California, 91010, United States
-
Colorado Blood Cancer Institute
Denver, Colorado, 80218, United States
-
Fred Hutchinson Cancer Center
Seattle, Washington, 98109, United States
-
MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
Mayo Clinic
Phoenix, Arizona, 85054, United States
-
Mayo Clinic
Jacksonville, Florida, 32224, United States
-
Mayo Clinic
Rochester, Minnesota, 55902, United States
-
Northwestern Memorial Hospital
Chicago, Illinois, 60611, United States
-
Roswell Park Comprehensive Cancer Center
Buffalo, New York, 14203, United States
-
Texas Oncology-PA USOR
Dallas, Texas, 75251, United States
-
University of California, San Francisco
San Francisco, California, 94143, United States
-
University of Kentucky - Markey Cancer Center
Lexington, Kentucky, 40536, United States
-
Virginia Cancer Specialists
Gainesville, Virginia, 20155, United States
-
Winship Cancer Institute, Emory University
Atlanta, Georgia, 30322, United States
Conditions
Explore the condition pages connected to this study.